Advertisement
Advertisement
Cerebrolysin

Cerebrolysin

Manufacturer:

EVER Neuro Pharma

Distributor:

Schumit
Concise Prescribing Info
Contents
Porcine brain-derived peptide
Indications/Uses
Organic, metabolic & neurodegenerative brain disorders. Post-apoplectic complications. Craniocerebral & post-op trauma, cerebral contusion or concussion.
Dosage/Direction for Use
IM/IV Up to 5 mL IM; up to 10 mL undiluted IV; or 10-50 mL slow IV infusion after dilution over 15-60 min. Organic, metabolic & neurodegenerative brain disorders (dementia) 5-30 mL. Post-apoplectic complications, craniocerebral trauma 10-50 mL. Childn 1-2 mL. All doses are given daily over 10-20 days. May reduce dose frequency to 2 or 3 times/wk after initial course.
Contraindications
Hypersensitivity. Epilepsy. Severe renal impairment.
Special Precautions
Allergic diathesis. Not to be mixed concomitantly w/ vit & CV drugs in the syringe. Epileptic conditions & grand mal convulsions. Increased seizure frequencies. Severe renal failure. Pregnancy & lactation.
Adverse Reactions
Feelings of heat or sweating, dizziness; inj site reactions eg, erythema, pruritus & burning.
Drug Interactions
Additive effects w/ anti-depressants or MAOIs. Not to be mixed w/ balanced amino acid soln.
MIMS Class
Nootropics & Neurotonics/Neurotrophics
ATC Classification
C04A - PERIPHERAL VASODILATORS ; Used as peripheral vasodilators.
Presentation/Packing
Form
Cerebrolysin soln for inj 10 mL
Packing/Price
(hosp pack) 50 × 1's;5 × 1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement